Basic Information
| LncRNA/CircRNA Name | TI09485 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | Microarray, qPCR, RNAi, Western blot, RIP etc. |
| Sample | cervical cancer tissues, cell lines (HeLa, SiHa, CaSki) |
| Expression Pattern | down-regulated |
| Function Description | LncRNA expression was then analyzed in CC cells and normal, primary cervical epithelial cells in the same manner. The levels of TI17313, TI13831, TI10124, and TI18318 were increased in 3 cancer cell lines (HeLa, SiHa, and CaSki) when compared with normal, primary cervical epithelial cells. Expression of the 5 other lncRNAs was below the level of detection in cultured cells. |
| Pubmed ID | 25007342 |
| Year | 2014 |
| Title | Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. |
External Links
| Links for TI09485 | GenBank HGNC NONCODE |
| Links for cervical cancer | OMIM COSMIC |